IP Library Granted Patent US 11,992,656
Granted Patent B2
US 11,992,656 · App. 17/005,939 · Granted May 28, 2024

Controlling medical infusion device operation and features based on detected patient sleeping status

Inventors: Lavie Golenberg (Bloomfield Hills, MI); Louis J. Lintereur (Stevenson Ranch, CA); Benyamin Grosman (Valley Village, CA); Di Wu (Glendale, CA); Maria Diana Miller (Santa Rosa Valley, CA)
Assignee: MEDTRONIC MINIMED, INC.
A61M5/1723A61B5/4809A61B5/746A61M5/14248A61M2205/18A61M2205/505A61M2205/52A61M2205/581A61M2205/582A61M2205/583A61M2205/587A61M2205/8206A61M2230/005A61M2230/201A61M2230/63
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,992,656
App. No.
17/005,939
Granted
May 28, 2024
Kind
B2
Abstract

A method of operating an insulin infusion device involves: operating the infusion device in an automatic mode to automatically control delivery of insulin to a user, in accordance with a first target glucose setpoint value; receiving user status data that indicates sleeping status of the user, the user status data generated by a sleep detection system; and determining, from the user status data, that the user is sleeping while the insulin infusion device is operating in the automatic mode. In response to the determining, the method transitions from the first target glucose setpoint value to a second (different) target glucose setpoint value for use during the automatic mode, the transitioning occurring without user input. The method continues to operate the infusion device in the automatic mode to automatically control delivery of insulin to the user, in accordance with the second target glucose setpoint value.

Claims (67)

1. A method of operating an insulin infusion device comprising a fluid pump mechanism and at least one controller that regulates operation of the fluid pump mechanism to deliver insulin from the insulin infusion device, the method comprising:

operating the insulin infusion device in an automatic mode to automatically control delivery of insulin to a user, in accordance with a first target glucose setpoint value;

receiving user status data that indicates sleeping status of the user, the user status data being sensor data generated by a sleep detection system;

determining, from the user status data, that the user is sleeping while the insulin infusion device is operating in the automatic mode;

in response to the determining, transitioning from the first target glucose setpoint value to a second target glucose setpoint value for use during the automatic mode, the transitioning occurring without user input, and the second target glucose setpoint value being different from the first target glucose setpoint value; and

continuing to operate the insulin infusion device in the automatic mode to automatically control delivery of insulin to the user, in accordance with the second target glucose setpoint value.

2. The method of claim 1 , wherein the second target glucose setpoint value is lower than the first target glucose setpoint value.

3. The method of claim 1 , further comprising:

receiving additional user status data that indicates sleeping status of the user, the additional user status data generated by the sleep detection system;

determining, from the additional user status data, that the user is awake;

in response to determining that the user is awake, transitioning from the second target glucose setpoint value to the first target glucose setpoint value without user input; and

continuing to operate the insulin infusion device in the automatic mode to automatically control delivery of insulin to the user, in accordance with the first target glucose setpoint value.

4. The method of claim 1 , wherein:

the user status data includes a sleep quality metric for the user, the sleep quality metric generated by the sleep detection system; and

the transitioning adjusts the first target glucose setpoint value as a function of the sleep quality metric to obtain the second target glucose setpoint value.

5. The method of claim 1 , wherein:

the user status data includes a sleep duration metric for the user, the sleep duration metric generated by the sleep detection system; and

the transitioning adjusts the first target glucose setpoint value as a function of the sleep duration metric to obtain the second target glucose setpoint value.

6. The method of claim 1 , wherein:

the sleep detection system is separate and distinct from the insulin infusion device; and

the insulin infusion device performs the receiving, determining, and transitioning steps.

7. The method of claim 1 , wherein:

the insulin infusion device comprises the sleep detection system; and

the insulin infusion device performs the receiving, determining, and transitioning steps.

8. The method of claim 1 , wherein:

the receiving and determining steps are performed by an ancillary control system that communicates with the insulin infusion device; and

the ancillary control system sends at least one command to the insulin infusion device, the at least one command causing the insulin infusion device to perform the transitioning.

9. The method of claim 1 , wherein the transitioning gradually adjusts the first target glucose setpoint value to the second target glucose setpoint value over a predetermined period of time.

10. The method of claim 1 , further comprising:

monitoring a sleep duration of the user; and

initiating the transitioning when the sleep duration exceeds a threshold time period.

11. An insulin infusion device comprising:

a fluid pump mechanism;

at least one controller that regulates operation of the fluid pump mechanism to deliver insulin from the insulin infusion device; and

at least one memory element associated with the at least one controller, the at least one memory element storing processor-executable instructions configurable to be executed by the at least one controller to perform a method of controlling operation of the insulin infusion device, the method comprising:

operating the insulin infusion device in an automatic mode to automatically control delivery of insulin to a user, in accordance with a first target glucose setpoint value;

receiving user status data that indicates sleeping status of the user, the user status data being sensor data generated by a sleep detection system;

determining, from the user status data, that the user is sleeping while the insulin infusion device is operating in the automatic mode;

in response to the determining, transitioning from the first target glucose setpoint value to a second target glucose setpoint value for use during the automatic mode, the transitioning occurring without user input, and the second target glucose setpoint value being different from the first target glucose setpoint value; and

continuing to operate the insulin infusion device in the automatic mode to automatically control delivery of insulin to the user, in accordance with the second target glucose setpoint value.

12. The insulin infusion device of claim 11 , wherein the insulin infusion device receives the user status data directly from the sleep detection system.

13. The insulin infusion device of claim 11 , wherein the method performed by the at least one controller further comprises:

receiving additional user status data that indicates sleeping status of the user, the additional user status data generated by the sleep detection system;

determining, from the additional user status data, that the user is awake;

in response to determining that the user is awake, transitioning from the second target glucose setpoint value to the first target glucose setpoint value without user input; and

continuing to operate the insulin infusion device in the automatic mode to automatically control delivery of insulin to the user, in accordance with the first target glucose setpoint value.

14. The insulin infusion device of claim 11 , wherein:

the user status data includes a sleep quality metric for the user, the sleep quality metric generated by the sleep detection system; and

the transitioning adjusts the first target glucose setpoint value as a function of the sleep quality metric to obtain the second target glucose setpoint value.

15. The insulin infusion device of claim 11 , wherein:

the user status data includes a sleep duration metric for the user, the sleep duration metric generated by the sleep detection system; and

the transitioning adjusts the first target glucose setpoint value as a function of the sleep duration metric to obtain the second target glucose setpoint value.

16. The insulin infusion device of claim 11 , wherein the transitioning gradually adjusts the first target glucose setpoint value to the second target glucose setpoint value over a predetermined period of time.

17. The insulin infusion device of claim 11 , wherein the method performed by the at least one controller further comprises:

monitoring a sleep duration of the user; and

initiating the transitioning when the sleep duration exceeds a threshold time period.

18. A system comprising:

an insulin infusion device that regulates delivery of insulin to a user;

a sleep detection system configured to generate user status data that includes sensor data and indicates sleeping status of the user, and configured to communicate the user status data; and

at least one controller that controls operation of the insulin infusion device, the at least one controller configured to:

operate the insulin infusion device in an automatic mode to automatically control delivery of insulin to the user, in accordance with a first target glucose setpoint value;

receive the user status data generated by the sleep detection system;

determine, from the user status data, that the user is sleeping while the insulin infusion device is operating in the automatic mode;

in response to determining that the user is sleeping, transition from the first target glucose setpoint value to a second target glucose setpoint value for use during the automatic mode, the transitioning occurring without user input, and the second target glucose setpoint value being different from the first target glucose setpoint value; and

continue to operate the insulin infusion device in the automatic mode to automatically control delivery of insulin to the user, in accordance with the second target glucose setpoint value.

19. The system of claim 18 , wherein the insulin infusion device comprises the at least one controller.

20. The system of claim 18 , wherein the sleep detection system comprises a gesture-based, motion-based, or activity-based detection system.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2021
From: GOLENBERG, LAVIE; LINTEREUR, LOUIS J.; GROSMAN, BENYAMIN; WU, DI; MILLER, MARIA DIANA
To: MEDTRONIC MINIMED, INC.
Reel/Frame 056724/0915 →